ACADIA Pharmaceuticals
ACAD
#3508
Rank
A$5.87 B
Marketcap
A$34.72
Share price
-2.14%
Change (1 day)
15.88%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): A$0.43 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are A$1.04 Billion. In 2024 the company made an earning of A$0.36 Billion, an increase over its 2023 earnings that were of -A$73.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.43 B16.83%
2024 A$0.36 B-605.67%
2023 -A$73.14 Million-76.09%
2022 -A$0.31 Billion27.41%
2021 -A$0.25 Billion-40.38%
2020 -A$0.41 Billion19.88%
2019 -A$0.34 Billion-3.92%
2018 -A$0.35 Billion-15.04%
2017 -A$0.42 Billion6.33%
2016 -A$0.39 Billion64.55%
2015 -A$0.24 Billion77.47%
2014 -A$0.14 Billion143.69%
2013 -A$54.38 Million81.93%
2012 -A$29.89 Million-8.73%
2011 -A$32.75 Million-251.39%
2010 A$21.63 M-133.2%
2009 -A$65.16 Million-30.82%
2008 -A$94.19 Million6.43%
2007 -A$88.5 Million25.89%
2006 -A$70.3 Million36.99%
2005 -A$51.32 Million37.22%
2004 -A$37.4 Million19.96%
2003 -A$31.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.42 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.98 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.24 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.51 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-A$0.18 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-A$55.36 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA